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ABSTRACT
Sensory photoreceptors have enabled non-invasive
and spatiotemporal control of numerous biologi-
cal processes. Photoreceptor engineering has ex-
panded the repertoire beyond natural receptors, but
to date no generally applicable strategy exists to-
wards constructing light-regulated protein actuators
of arbitrary function. We hence explored whether
the homodimeric Rhodobacter sphaeroides light-
oxygen-voltage (LOV) domain (RsLOV) that dissoci-
ates upon blue-light exposure can confer light sensi-
tivity onto effector proteins, via a mechanism of light-
induced functional site release. We chose the RNA-
guided programmable DNA endonuclease Cas9 as
proof-of-principle effector, and constructed a com-
prehensive library of RsLOV inserted throughout
the Cas9 protein. Screening with a high-throughput
assay based on transcriptional repression in Es-
cherichia coli yielded paRC9, a moderately light-
activatable variant. As domain insertion can lead
to protein destabilization, we also screened the li-
brary for temperature-sensitive variants and isolated
tsRC9, a variant with robust activity at 29◦C but negli-
gible activity at 37◦C. Biochemical assays confirmed
temperature-dependent DNA cleavage and binding
for tsRC9, but indicated that the light sensitivity
of paRC9 is specific to the cellular setting. Using
tsRC9, the first temperature-sensitive Cas9 variant,
we demonstrate temperature-dependent transcrip-
tional control over ectopic and endogenous genetic
loci. Taken together, RsLOV can confer light sensi-
tivity onto an unrelated effector; unexpectedly, the
same LOV domain can also impart strong tempera-
ture sensitivity.
INTRODUCTION
Sensory photoreceptors are the biological agents that me-
diate light sensation in manifold organisms. Photorecep-
tors comprise photosensor modules which absorb incident
light and effector modules which possess biological activity
and elicit downstream physiological adaptations (1). This
modular, genetically encodable architecture lends itself to
the engineering of novel photoreceptors via recombination
of photosensors and effectors (2). Engineered photorecep-
tors not only serve as light-regulated actuators in opto-
genetics, but also provide mechanistic insight into princi-
ples of signal transduction. The two most versatile and suc-
cessful photoreceptor engineering strategies to date (2) rely
on light-regulated order-disorder transitions (3) and light-
regulated association reactions (4), respectively. Although
numerous effector activities have thus been subjected under
light control, no generally applicable route towards creat-
ing photoactivatable variants of arbitrary effectors yet ex-
ists, especially in case the effector is monomeric and no
natural regulatory mechanism is known (2). To expand
the repertoire of available strategies, we set out to explore
the potential of the photoreceptor RsLOV (5) (Figure 1a)
from Rhodobacter sphaeroides for the engineering of light-
regulated protein actuators.RsLOVbelongs to the family of
light-oxygen-voltage (LOV) photoreceptors (6) that employ
flavin nucleotide chromophores to respond to blue light.
In its dark-adapted form, RsLOV predominantly assumes
homodimeric state with the dimer interface formed by an-
cillary helices N-terminal (A’ helix) and C-terminal (J
and K) to the LOV core domain. Blue-light absorption
promotes reversible dissociation into two monomers. No-
tably, RsLOV thus displays signal polarity opposite to that
of several LOV photosensor domains, which undergo light-
induced homo- or hetero-association (2,7,8). We reasoned
that this unorthodox response to light could be exploited
in photoreceptor engineering, via light-induced release of
steric occlusion: in this approach, the RsLOV photosensor
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Figure 1. RsLOVmechanism and creation of the (d)Cas9-RsLOV domain insertion library. (A) The photoreceptor RsLOV (PDB ID 4hj6) is a homodimer
in the dark-adapted state but dissociates upon blue light exposure. (B) Cas9 is an RNA-guided DNA endonuclease. In the catalytically incapacitated form,
dCas9 serves as an RNA-guided DNA binding protein. Cas9, gRNA, target DNA, and recognition sequence are shown in green, black, gray and orange,
respectively. (C) Hypothetical mechanism of light regulation in a RsLOV-(d)Cas9 chimera. In the dark-adapted dimeric state, the (d)Cas9 functional site
is sterically blocked through dimerization via RsLOV (dark purple ellipse). Light-induced dissociation leads to functional site release and restoration of
activity. (D) 234 chosen insertion sites (blue) mapped onto the Cas9 apo structure (green, PDB ID 4cmp). (E) Cloning of a defined RsLOV-dCas9 domain
insertion library via Multiplex-Inverse PCR (MIP). For every insertion site, the dCas9 plasmid (green/black) is amplified with ‘outward-facing’ primers
annealing at that site. The ‘linearized’ plasmids are then pooled and ligated with RsLOV gene fragments (blue).
would be coupled with target effectors such that in the dark,
unproductive dimeric complexes are formed with the effec-
tor active site sterically blocked. Light exposure would pro-
mote complex dissociation, release of steric occlusion and
restoration of effector function.
To test these concepts, we selected the RNA-guided
sequence-specific DNA endonuclease Cas9 from Strepto-
coccus pyogenes (9) as the target effector because of its emi-
nent biological relevance (10) and the availability of power-
ful screening assays. Cas9 can be programmed to cleave ar-
bitrary DNA sequences with high specificity through a so-
called guide-RNA (gRNA) reverse complementary to the
target site (Figure 1B). This easy programmability hasmade
Cas9 an indispensable tool for genome engineering across
a wide range of organisms and tissues (11). Further, a cat-
alytically inactive variant of Cas9, denoted dCas9, serves
as a programmable, sequence-specific DNA-binding pro-
tein (12), thereby allowing precise control of transcriptional
activity (12–14) and epigenetic modifications (15) of en-
dogenous genetic loci. So far, only few natural mechanisms
are known by which the molecular activity of CRISPR-
Cas effectors are regulated (16), and the existence of nat-
urally light-switchable (d)Cas9 variants appears unlikely.
Such variants would be of interest for at least two reasons:
(i) the ‘classical’ optogenetic premise of precise spatiotem-
poral control over cellular activities of interest (17); (ii)
genome engineering efficiencies are hampered by off-target
activity (18) and long DNA residence times (19). Cas9 vari-
ants with regulable activity might offer a way of mitigating
these unwanted side effects.
In addition to split-Cas9 (20) and ligand-sensitive (21)
Cas9 variants, two light-responsive Cas9 variants have re-
cently been engineered. First, a critical lysine residue was
modified with a photolabile protecting group, and Cas9
thereby inactivated (22). UV irradiation led to release of
the protecting group and restoration of Cas9 activity. Al-
though the light response showed a high dynamic range, the
system is limited by the use of potentially harmful UV irra-
diation, irreversible photolysis of the protecting group and
the need for incorporating unnatural amino acids. Second,
Cas9 was split in two halves and linked to a heterodimeric
LOVphotoreceptor that reversibly associates upon light ab-
sorption (23). Activity of the split Cas9 protein could thus
be regained in blue-light-regulated manner and with high
dynamic range. This system relies on two separate polypep-
tide fragments, which might be of potential disadvantage in
certain contexts (2).
A single-chain, light-regulated (d)Cas9 variant based on
RsLOV could hence be a valuable addition to the exist-
ing repertoire. To this end, we constructed a comprehensive
domain-insertion library of variants where theRsLOV pho-
tosensor is placed at different sites throughout the dCas9
gene. Screening by flow cytometry for light-induced differ-
ences in transcriptional repression yielded a (d)Cas9 vari-
ant moderately activated by blue light. As insertions of
guest proteins frequently destabilize host proteins, we also
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tified another (d)Cas9 variant whose activity was strongly
inhibited when elevating the temperature from 29 to 37◦C.
While lacking the excellent spatiotemporal control afforded
by light, temperature variations offer an alternative means
of perturbing cellular events reversibly and non-invasively,
as we demonstrate by regulating expression from endoge-




The E. coli-based assay system for dCas9 activity (Figure
2a, Supplementary Figure S1) consists of three separate
plasmids. First, we subcloned the dCas9 gene into vector
pCDF-Ara that harbors a streptomycin resistance marker
and an arabinose–inducible promotor. Second, for use as a
fluorescence reporter, we resorted to plasmid pROB12 (24),
which confers kanamycin resistance and carries a dsRed-
ExpressII expression cassette under control of the IPTG-
inducible T7-lacO promotor. Third, to generate the sgRNA
chassis, we assembled by PCR a linear construct contain-
ing a constitutive J23119 promotor (12), a specific 20nt
gRNA sequence, and the 70nt constant sequence (9,12),
and cloned this linear construct into a pACYC184 vector
using HindIII/EagI sites. All enzymes were obtained from
Fermentas (Thermo) or New England Biolabs. To enable
multiplexing, a second J23119-sgRNA fragment was cloned
into the same vector using BglI/EheI sites. To determine a
sgRNA sequence yielding significant repression, we tried 5
different sequences in the 5′ region of theRFP gene (Supple-
mentary Information, Figure S1, S2) in combination with
dCas9. To run the assay, E. coli CmpX13 cells (25) car-
rying all three plasmids were grown to saturation without
any induction. The culture was then diluted 1:100 (when
assaying at 37◦C) or 1:1000 (29◦C), and dCas9 expression
was induced with 3 mM arabinose. After 1 h (37◦C) or 2 h
(29◦C), 1 mM IPTG was added to induce RFP expression.
After an additional 4 h (37◦C) or 15–16 h (29◦C), RFP flu-
orescence was measured with a Tecan M200pro microplate
reader (excitation 541 nm, emission 591 nm) and normal-
ized by OD600. Of the five sgRNAs tried (Supplementary
Figure S2), the two that showed the highest repression lev-
els (compared to empty sgRNAplasmid) were combined on
one pACYC184 plasmid for multiplexing. As measured by
flow cytometry, this double-sgRNA plasmid showed ∼350-
fold repression of RFP expression (Figure 2b) compared to
an empty pACYC184 plasmid, and was subsequently used
during library screening.
Modeling and cloning of RsLOV terminal extensions
To estimate the minimum number of residues necessary to
bring the RsLOV N- and C-termini into spatial proximity,
we used the Rosetta3 (26) Remodel module (27) to model
extensions of 16–22 amino acids on both the N- and C-
termini of the RsLOV crystal structure (5). Only the added
residues were treated as flexible during the calculations. To
guide sampling, a distance constraint of 6 A˚ was added
between the N-terminal and C-terminal residues. Rosetta3
command lines and XML input files are in the SI note 3.
For each extension length considered, 50 models were gen-
erated, and afterwards the number ofmodels countedwhere
the termini were within 6 A˚ of each other (Supplementary
Figure S3 and Table S1). For N- and C-terminal extensions,
a minimum number of 18 and 16 residues, respectively, was
found to be necessary. Based on these results, and to en-
sure library diversity, we decided to generate variants with
N- or C-terminal extensions of lengths 15, 20, 23, 26 and 29
residues, and also one variant carrying 15 residue extensions
on both termini. To ensure the extensions were flexible,
the sequence was chosen to consist of Gly/Ser/Ala/Thr re-
peats. All variants were generated by combining theRsLOV
gene, obtained as a gift from Brian Crane (5), with oligonu-
cleotides encoding the extension sequence through PCR as-
sembly.
Cloning the Cas9-RsLOV ‘Multiplex inverse PCR‘ (MIP) in-
sertion library
The 234 insertion sites in Cas9 were chosen based on vi-
sual inspection of the apo crystal structure (28) (see SI note
4 for list). To build MIP-type insertion libraries (29), two
problems need to be solved: (i) how to design the hun-
dreds of primer sets and run the corresponding individ-
ual PCR reactions with manageable amount of labor; and
(ii) how to efficiently ligate the linear vector and insert
PCR fragments. For (i), we wrote a Python script (avail-
able at https://github.com/flosopher/floscripts/blob/master/
genutils/InsertPrimerDesigner.py) that designs the two out-
ward facing MIP primers for each site while attempting to
keep the melting temperatures of both as similar as pos-
sible (Supplementary Figure S4). For (ii), we added NotI
(at the 5′ RsLOV fwd primer/Cas9 MIP rev primer) and
SalI (RsLOV 3′ rev primer / Cas9 MIP fwd primer) re-
striction sites to allow for efficient directional cloning. The
restriction sites are translated as Ala-Ala-Ala (NotI) or
Gly-Ser-Thr (SalI), ensuring that the linkers connecting
the Cas9 insertion sites to the (extended) RsLOV are flex-
ible. The 234 primer pairs were ordered in 96-well plates,
sorted row-wise by ascending melting temperature. PCR re-
actions for 231 primer pairs were successful. These were
pooled, gel-purified (Macherey-Nagel PCR cleanup kit),
and digested with NotI and SalI. In parallel, the 11 dif-
ferent RsLOV linker/extension variants were amplified by
PCR with primers containing NotI and SalI sites. The re-
sulting products were pooled, treated with NotI/SalI, lig-
ated to the digested dCas9 pool, transformed into NEB-5
(New England Biolabs) cells, and plated. To ensure good
coverage of the 11×231 = 2541 theoretically expected vari-
ants in the library, enough transformation reactions for∼20
000 colonies were carried out. Plasmids were prepared from
these colonies (Macherey-Nagel plasmid isolation kit) and
used to transform E. coli CmpX13 cells already containing
the RFP reporter and gRNA plasmids.
Fluorescence-activated cell sorting (FACS) to identify switch-
able constructs
CmpX13 cells containing the dCas9-RsLOV insertion li-
brary plus RFP and gRNA plasmids were cultured as de-
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Figure 2. Screening of the RsLOV-dCas9 insertion library for light- and temperature-switchable constructs. (A) Targeting of dCas9 to the 5′ coding region
of an RFP reporter gene causes RNA polymerase (pink circle) to stall and results in reduced RFP expression. Switchable RsLOV-dCas9 chimeras can
thus be isolated by alternately screening for low and high fluorescence. (B) Fluorescence population of the naı¨ve RsLOV-dCas9 library at 37◦C (orange)
and 29◦C (gray), with positive (dCas9 +gRNA, green) and negative (dCas9 –gRNA, red) controls shown for comparison. At 37◦C, the library is virtually
indistinguishable from the negative control population, indicative of most constructs being inactive. At 29◦C, a broad shoulder towards the positive control
population indicates the presence of several constructs functional at this lower temperature. (C) Isolation of tsRC9. After two rounds of screening for
functional constructs at 29◦C, tsRC9was isolated, which shows dCas9-like activity at 29◦C (gray) but virtually no activity at 37◦C (orange). (D) Screening for
light-switchable constructs. After 7 rounds of screening for high activity under blue-light irradiation (blue) and low activity in the dark (grey), constructs of
intermediate activity were enriched and a small light/dark difference appeared. Two switchable constructs, paRC9A and B, were isolated from the enriched
library. (E) Optimization of paRC9A. After computational modeling and screening of mutations stabilizing RsLOV, a variant with improved repression
under blue-light vs. dark conditions was obtained. (F) Median fluorescence values of all constructs from panels B-E. paRC9 has 6.5-fold dynamic range
(shown are the mean and standard deviation (SD) of three individual measurements).
cm−2 470 nm irradiation. After 16–19 h (29◦C) or 4 h
(37◦C), cultures were chilled on ice, diluted 1:100 into ice-
cold PBS buffer, and this suspension was analyzed and
sorted on a BD FACS Aria II cell sorter. All events with
a forward scatter area >4000 units and a sideward scat-
ter area >7000 units were considered as cells. The PE-
Texas-Red channel was used for RFP expression analysis.
The negative control (dCas9, empty gRNA plasmid) had
a peak at 1.6×104 RFU (relative fluorescence units), the
positive control (dCas9 with gRNA) at 5*101 RFU. (Fig-
ure 2B). The fluorescence range was thus divided into four
regions: P1 (well working, fluorescence < 5×102 RFU),
P2 (rather working, 5×102 RFU < fluorescence < 2×103
RFU), P3 (rather non-functional, 2×103 RFU < fluores-
cence < 8×103 RFU) and P4 (non-functional, fluorescence
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P1L-P3D (meaning cells showing P1 fluorescence after be-
ing cultivated under blue light and P3 fluorescence after cul-
tivation in darkness), P1L-P4D and P2L-P4D. A screen-
ing cycle consisted of selecting ∼30 000 cells cultured un-
der blue light for low fluorescence (i.e. P1 or P2), sorting
into fresh LB without inducers, growing to saturation, then
diluting 1:1000 and induction/cultivation in darkness, fol-
lowed by sorting 30 000 cells of high fluorescence (P3 or P4).
paRC9A and Bwere isolated from the P2L-P4D population
after seven sorting steps.
Cloning of the paRC9A linker library
The objective of this library was to simultaneously sample
insertion site (Cas9 residues 468–481), linker length (7, 9,
12, 15, 19 amino acids), and linker sequence.We defined the
minimum linker length (seven residues/21nt) on each side as
an overlap forGibson assembly (30), and orderedMIP-style
primers carrying this overlap on their 5′ end for each of the
14 insertion points. Fourteen individual PCR reactionswere
carried out and the products pooled. For theRsLOV inserts,
five primers for eachN- andC-terminus lengthwere ordered
consisting of the 5′ overlap sequence, a 3′ sequence comple-
mentary to the respective RsLOV terminus, and an inter-
mediate sequence of the respective length. For the primers
to create linkers of 9, 12, 15, and 19 amino acids, one
to two degenerate codons encoding four to eight different
residues were added to the intermediate sequence. Twenty
five PCRs (5N-terminal primers * 5C-terminal primers) for
the RsLOV inserts were done, which, when combined with
the sequence degeneracy, yielded a total of 990 theoretical
RsLOV linker variants. The 25 products were pooled and
combined with the MIP-PCR pool through Gibson assem-
bly (30), yielding a library of theoretical size 14 000. Screen-
ing by FACS was carried out as described above.
Rosetta modeling of RsLOV stabilizing mutations and
cloning of the library
Modeling of mutations stabilizing the RsLOV C-terminal
helices was done analogously to the work of Guntas et al.
(31). Briefly, at 50 positions in the intramolecular interface
between the C-terminal helices and the central -sheet, all
residue identities observed at a given position in a BLAST
alignment of RsLOV were considered for mutation, lead-
ing to a total of 610 possible single point mutants. In ad-
dition, all double mutations within this set where the C
atoms were within 10 A˚ of each other (a total of 42722)
were also considered. TheRosetta3 pmut scan protocol was
used to calculate theoretical G values for all 43332 sin-
gle and double mutants, and models of mutants having a
G of <–0.3 Rosetta Energy units (REU) (single)/<–0.6
REU (double) were visually inspected (35 single and 102
double mutants). After visual inspection, a total of 16 mu-
tations at 11 positions were chosen for incorporation into
a library containing these point mutants and all combina-
tions thereof, with a theoretical size of 13824 (Supplemen-
tary Table S2). Degenerate oligonucleotides containing the
desired mutations were used to assemble the mutagenized
RsLOV gene (Supplementary Figure S5). Gibson overlaps
at the N- and C-termini of RsLOV were defined. A PCR
withMIP-type primers carrying the same overlaps and with
templates isolated from the linker library was run, and the
resulting product combined with the mutated RsLOV gene
via Gibson assembly (30). Screening by FACS was carried
out as described above.
-Galactosidase assays
The sgRNAs against lacZ and lacI published by Qi et al.
(12) were cloned into the pACYC184 plasmid and trans-
formed into CmpX13 cells together with plasmids express-
ing paRC9, tsRC9 or dCas9. Cultures were grown to satura-
tion without inducers, then diluted 1:100 into LB contain-
ing 1.5 mM arabinose to induce dCas9 variants and grown
for 1 h. Then, 1 mM IPTG was added for samples con-
taining lacZ gRNA, and the cultures were grown for an-
other 4 h (37–35◦C), 5 h (34–32◦C) or 6 h (31–29◦C). -
Galactosidase activity was quantified using the Pierce yeast
-galactosidase assay kit following the manufacturer’s in-
structions.
Protein expression and purification
Escherichia coli CmpX13 were transformed with pCDF
vectors expressing the C-terminally His-tagged paRC9 or
tsRC9. 800 ml LB culture supplemented with 50 M ri-
boflavin and 35 g/ml streptomycin were inoculated with
800 l of overnight cultures and grown at 37◦C and 225
rpm to an OD600 of 0.5. The cultures were chilled at 16◦C
and 225 rpm for 30 min prior to induction with 3 mM
arabinose and incubation for 19 h at 16◦C and 225 rpm.
The cells were harvested at 4000 × g and 4◦C for 10 min
and resuspended in 20 ml lysis buffer (50 mM Tris–HCl
pH 8.5, 300 mM NaCl, 10 mM imidazole and protease in-
hibitor cocktail Complete Ultra (Roche, Mannheim, Ger-
many)). After lysis by sonication, the cleared lysate was pu-
rified by gravity-flow Co2+-NTA affinity chromatography
(HisPur Cobalt Resin, Thermo Scientific, Bonn, Germany).
The protein was eluted with buffer containing 300 mM im-
idazole and dialyzed against 25 mM Tris HCl pH 8.5, 300
mM NaCl, 10% (v/v) glycerol. After concentration with a
50 kDa cutoff centrifugal filter device (Sartorius) protein
concentration was quantified through the FMN cofactor
peak at 450 nmusing an extinction coefficient of 12 500M−1
cm−1, and aliquots were flash frozen and stored at −80◦C.
Cleavage assays
Kinetic cleavage assays were performed by first preincubat-
ing Cas9 variants at 50 nM in KGB (32) under applica-
ble light/temperature conditions (29◦C or 37◦C for tsRC9,
dark or under blue light at 29◦C for paRC9) for 10min,
then adding 100 nM prehybridized dual-crRNA:tracrRNA
of Streptococcus pyogenes targeting speM protospacer (33)
and incubating for another 15min. Plasmid DNA contain-
ing speMwas then added to a final concentration of 10 nM.
After defined timepoints (1, 2, 5, 10, 20, 40 and 60 min)
samples were withdrawn and the reaction was stopped by
addition of 5× loading buffer (34). Cleavage reactions were
analyzed by gelelectrophoresis on 0.8% agarose gels in 1×
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of cleavage of at least three individual experiments was de-
termined by densiometry and plotted against time.
Electrophoretic mobility shift assay
A 90-base pair PCR product containing speM protospacer
was 5′ radiolabeled using [ -32P] ATP (Hartmann Analyt-
ics) and T4 polynucleotide kinase (Fermentas) according to
the manufacturer’s manual. The labelled substrate was pu-
rified using QIAquick PCR purification Kit (Qiagen). Cas9
variants were preincubated at applicable conditions (29◦C
or 37◦C for tsRC9, dark or under blue light at 29◦C for
paRC9) in DNA-binding buffer (20 mM Tris HCl pH 7.4,
100 mM KCl, 5 mM CaCl2, 1 mM DTT, 5% (w/v) glyc-
erol, 20 ng/l poly(dI-dC)) for 10 min, then mixed with
two-fold molar excess of prehybridized dual-RNA and in-
cubated for another 10 min followed by addition of 5 nM
labelled DNA substrate. Binding reactions were then incu-
bated for 1 h. The samples were loaded on a native 6% poly-
acrylamide gel, which was then run at 10 V cm−1 for 45 min
in 0.5×TBE supplementedwith 5mMCaCl2. The gels were
exposed on autoradiography films and visualized by phos-
phorimaging. Percentage of bound DNA for at least three
independent experiments was determined by densiometry
and plotted against the protein concentration used (0, 15,
30, 40, 50, 60, 80, 100, 120, 200 nM). The apparent dissoci-
ation constant (KD) was determined by least-squares fitting
to the Hill equation (fraction bound = [protein]n/(KDn +
[protein]n)).
RESULTS
Construction of a RsLOV-Cas9 insertion library
We reasoned that the Cas9 effector could be rendered light-
switchable if covalently linked with the RsLOV photosen-
sor such that in the dark, a dimeric complex with a steri-
cally occluded functional site is formed (Figure 1C). Blue-
light absorption would promote dissociation of the com-
plex, and access to the functional site would be restored. To
achieve this regulatory mechanism, photosensor and effec-
tor must be linked such that (i) their individual function and
structures are only minimally perturbed; and ii) RsLOV-
mediated dimerization results in steric blockade of the Cas9
functional site. Despite the availability of high-resolution
structures of both entities (5,28,35), chimeric constructs
that meet these two criteria are hard to predict. We hence
opted for construction of a library of RsLOV inserted at
several surface-exposed sites throughout the dCas9 effector,
and for screening this library for light-regulated variants.
Inspection of the RsLOV structure reveals its N- and
C-termini to be separated by ∼40 A˚ (Supplementary Fig-
ure S3), meaning that insertion into Cas9 or other pro-
teins would almost inevitably result in severe and detrimen-
tal structural distortions. To overcome this limitation, it is
necessary to add linkers sufficiently long for bringing the
termini into proximity. By computational design with flex-
ible backbone geometry (27), we found that at least 18 N-
terminal or 16 C-terminal residues are required to bridge
the two termini (Supplementary Figure S3). We hence gen-
erated ten variants of RsLOV with flexible linkers of 15, 20,
23, 26 or 29 residues appended at either N- or C-terminus,
plus one variant featuring 15 residues at both termini. Next,
based on visual inspection of the Cas9 crystal structure, we
picked 234 surface-exposed positions as insertion points,
on average corresponding to one insertion site for every
5.8 residues of Cas9 (Figure 1D). Combination of the 11
RsLOV photosensor variants with the 234 Cas9 effector in-
sertion sites, in theory gives rise to a library of 2574 unique
RsLOV-Cas9 chimeras. We cloned this library using the
‘Multiplex Inverse PCR’ (MIP) approach (Figure 1E) in-
troduced by Ostermeier and co-workers (29). Successful li-
brary construction was confirmed by DNA sequencing of
25 random clones, which all represented different variants
out of the 2574 theoretically expected.
High-throughput screening of RsLOV-Cas9 activity
To facilitate library screening, we established an E. coli-
based high-throughput assay following the CRISPR inter-
ference concept (CRISPRi) introduced by Qi et al. (12) and
Bikard et al. (13). Here, the dCas9 variant, which is catalyt-
ically inactive, yet retains RNA-guided sequence-specific
DNA binding, serves as a transcriptional repressor (Fig-
ure 2A). Directed to the promotor or 5′ region of a red-
fluorescent reporter (RFP) gene, dCas9 interferes with tran-
scription and thereby decreases expression of the target
gene. If, however, dCas9 is left out or rendered unable to
bind, transcriptional repression is relieved and highRFP re-
porter fluorescence is achieved. We adapted the setup by Qi
et al. toward a three-plasmid system (Supplementary Fig-
ure S1), and found that in the presence of dCas9 and two
gRNAs directed against the RFP, bacteria developed negli-
gible fluorescence, indicative of efficient transcriptional re-
pression. Omission of the gRNA yielded readily visible, ap-
proximately 350-fold elevated fluorescence (Figure 2B and
F, SI, Figure S2). Of particular advantage, the RFP repres-
sion assay lends itself to fluorescence-activated cell sorting
(FACS) of the RsLOV-dCas9 libraries and allows isolation
of clones harboring either binding-proficient dCas9 vari-
ants (screening for low fluorescence) or binding-deficient
dCas9 variants (screening for high fluorescence). In itera-
tive rounds, theRsLOV-dCas9 libraries were cultured under
alternating blue-light and dark conditions, and E. coli cells
were alternately sorted for low and high RFP fluorescence,
respectively.
Identification of temperature-sensitive and light-regulated
RsLOV-(d)Cas9 variants
Following cultivation at 29◦C in darkness or constant blue
light (470 nm, 100 W cm−2), the naı¨ve RsLOV-dCas9 li-
brary was analyzed by FACS (Figure 2B). As expected for
domain insertions (29), a large fraction of the variants in
the initial naı¨ve library were not functional, indicated by a
dominant peak at high fluorescence that corresponds to a
negative control (dCas9 without gRNA). A broad tail to-
ward lower fluorescence values, corresponding to a positive
control (dCas9 with gRNA), suggested that several vari-
ants were at least partially functional. No light/dark dif-
ference was visible in the initial library. When grown at
37◦C, the naı¨ve library displayed fluorescence levels almost
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majority of variants in the library are binding-deficient at
37◦C, in contrast to the findings at 29◦C. Evidently, the
library comprised constructs with strongly temperature-
dependent dCas9 activity. Following two rounds of screen-
ing for efficient repression at 29◦C, we isolated a variant, de-
noted tsRC9 (temperature-sensitiveRsLOV-Cas9), in which
RsLOV with a C-terminal linker of 21 residues is inserted
between residues N235 and G236 (Supplementary Figure
S6). tsRC9 is as competent as dCas9 at inhibiting RFP ex-
pression at 29◦C, but shows no repression activity at 37◦C
(Figure 2C and F). Blue light had no effect on transcrip-
tional repression by tsRC9. To investigate whether the ob-
served temperature-sensitivity is due to an intrinsic prop-
erty of RsLOV or is caused by perturbation of the (d)Cas9
structure around position 235, we created and tested vari-
ant tsRC9 GFPex. In this variant, the RsLOV insert is
exchanged for superfolder GFP (sfGFP), a single-domain
protein of comparable size to RsLOV and generally con-
sidered stable. tsRC9 GFPex shows negligible temperature-
sensitivity (Supplementary Figure S10), indicating that the
properties of tsRC9 are due to the RsLOV insert. This view
is further corroborated by the observation of a substan-
tial fraction of temperature-sensitive variants in the naı¨ve
RsLOV-dCas9 library.
To isolate a light-activatable RsLOV-Cas9 construct, we
alternately screened the naı¨ve library for cells displaying low
fluorescence after incubation under blue light (at 29◦C), fol-
lowed by screening for cells displaying high fluorescence af-
ter incubation in the dark. After seven rounds of screening
(4× light, 3× dark), the library showed a small but repro-
ducible difference between dark and blue-light conditions
(Figure 2D), indicating enrichment of light-activated con-
structs. Testing of individual clones from the enriched li-
brary yielded two clones, denoted paRC9A (photoactivat-
able RsLOV-Cas9 A) and paRC9B, that both showed re-
pression activity that was enhanced under blue light by fac-
tors of 3.4 (paRC9A) and 2.8 (paRC9B). DNA sequenc-
ing revealed that in paRC9A, RsLOV (with linkers of 15
residues at both termini) had been inserted between residues
F478 and E479 (Supplementary Figure S6), into a loop that
is disordered in the apo structure of Cas9 but mediates im-
portant interactions with the gRNA (28,35). In paRC9B,
RsLOV (with a 24-residue N-terminal linker) had been in-
serted between residues S1088 and M1089, in a domain of
Cas9 that contacts the 3′ end of the gRNA (Supplementary
Figure S6) (28,35). Notably, in all three isolated constructs,
RsLOV was inserted at Cas9 positions that were found to
be tolerant to domain insertion in a recent Cas9 engineer-
ing study (21).
Improving the dynamic range of paRC9A
The activity difference (dynamic range) between 29 and
37◦C observed for tsRC9 is on par with the activity differ-
ence between the dCas9 +gRNA positive and the dCas9
−gRNA negative controls. Hence, tsRC9 likely cannot be
much improved nor does it need to be. By contrast, the dy-
namic range of paRC9A/B needs to be enhanced before be-
coming useful in applications. In the past, engineered pho-
toreceptors were improved in their dynamic range by op-
timization of the photosensor itself (31) or by modulation
of the linkers connecting photosensor and effector (36,37).
We focused on optimizing paRC9A because of its higher
dynamic range compared to paRC9B and because of ini-
tial experiments indicating it was more optimizable (Sup-
plementary Figure S7).
We first varied the position at which RsLOV is inserted
into dCas9 as well as linker length and composition. To
this end, we constructed a library where the RsLOV pho-
tosensor was inserted at any of the 14 surface-exposed po-
sitions between K468 and V481 of dCas9. Moreover, a
set of N- and C-terminal linkers with 7, 9, 12, 15 or 19
residues were used, and additional linker sequence diver-
sity was introduced via PCR amplification with degenerate
oligonucleotide primers. Altogether, the theoretical library
size amounted to 14 000. Even after 10 rounds of screening
(cf. above), we failed to identify any significantly improved
variants; however, although none of the library members
had improved dynamic range, some showed lower or higher
RFP repression levels than paRC9A (Supplementary Table
S3, Figure S8).
We next reasoned that the dark activity of paRC9A could
be lowered and thus the dynamic range enhanced by stabi-
lizing the RsLOV photosensor dimer interface formed by
the A’, J and K helices. Analogous to a recent engi-
neering study on the Avena sativa phototropin1 LOV2 pho-
tosensor (31), we used computational modeling to identify
stabilizing mutations at the interface between these helices
and the central –sheet of RsLOV. We thus selected 16 po-
tentially stabilizing mutations at 11 residue positions and
incorporated them in a combinatorial library containing
13824 different RsLOV variants (Supplementary Table S2).
This library was combined with 10 variants isolated from
the previous, linker-based optimization round, thus yield-
ing a total library of ∼138 000 variants. Twelve rounds of
screening identified a construct (paRC9 from hereon) with
around two-fold improved dynamic range of 6.5 (Figure 2E
and F). The improvement was due to decreased dark-state
activity, in line with the design hypothesis. Sequencing of
paRC9 revealed it to have four residue exchanges (Q82V,
H102F, A164S, L168M in RsLOV numbering) relative to
wild-type RsLOV, thereby resulting in a more hydrophobic
sheet/helix interface (Supplementary Figure S9).
As controls, we created variants C548A (equivalent to
C55A in RsLOV) and Q611A (Q118A) of paRC9, thus re-
placing two residues in the RsLOV photosensor that are
critical for photochemistry and signal transduction (5,6,38).
The response to light was greatly diminished in these vari-
ants (Supplementary Figure S10), ascertaining that light-
sensitivity in paRC9 necessitates intact photochemical re-
action of the RsLOV photosensor.
Switchable DNA cleavage by tsRC9 and paRC9 in E. coli
Although efficient with a throughput of ∼ 107–108 (limited
by cloning efficiency and event rate of the flow cytometer),
the above dCas9 screening assay has the drawback of being
based on DNA binding rather than cleavage. To ascertain
whether tsRC9 and paRC9 possess switchable DNA cleav-
age activity, we also tested these variants in the catalytically
active Cas9 background. Within the above E. coli-based
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Figure 3. Cleavage activity of paRC9 and tsRC9 in E. coli. paRC9 and
tsRC9 were co-expressed in the cleavage-competent Cas9 context with a
gRNA targeting a plasmid conferring kanamycin-resistance. Plating on se-
lective media under the respective ‘off’ condition (37◦C for tsRC9, dark
for paRC9) yielded colonies at counts similar (tsRC9) or reduced (paRC9)
compared to dCas9, but no colonies (n.d. = not detected) in the respective
‘on’ condition (29◦C for tsRC9, 30 W cm−2 470 nm light for paRC9).
Shown are mean ± SD of three individual experiments.
to degradation of the RFP-expressing plasmid which con-
fers resistance to kanamycin. When grown on kanamycin-
containing agar plates, clones expressing a Cas9 control ac-
cordingly did not grow but those expressing the cleavage-
incompetent dCas9 control formed colonies (Figure 3).
When testing paRC9 in this assay, bacterial colonies only
formed under dark conditions, although at reduced size and
count (CFU, colony-forming units) compared to the dCas9
control. These results indicate light-activated cleavage ac-
tivity of paRC9. In case of tsRC9, CFU counts compa-
rable to dCas9 were observed at 37◦C (although colonies
were smaller), but no colonies were visible after incubation
at 29◦C. These results suggest that tsRC9 shows strongly
temperature-switchable cleavage activity, but in contrast to
the RFP repression case, there seems to be residual activity
at 37◦C.
Biochemical investigation of DNA binding and cleavage by
tsRC9 and paRC9
Having isolated tsRC9 and paRC9, we next investigated
whether the activities of these variants are allosterically reg-
ulated at the molecular level, or whether they constitute so-
called ‘phenotypic’ switches that show switchable activity
in cellular but not in biochemical assays. Previous efforts
to develop switchable proteins by combining sensor and ef-
fector domains (39,40) have yielded both ‘true’ allosteric
molecules as well as ‘phenotypic’ constructs. Activity dif-
ferences of the latter can often be attributed to increased
cellular protein accumulation in the ‘on’ condition of the
switch (40).
We expressed and purified paRC9 and tsRC9 in the
cleavage-competent Cas9 background. Absorption spec-
troscopy confirmed correct incorporation of the flavin chro-
mophore and intact LOV photochemical response. We first
performed cleavage assays with dual crRNA:tracrRNA di-
rected against a unique target site within a 7700 base-
pair supercoiled plasmid. At 29◦C, tsRC9 readily catalyzed
DNA cleavage, albeit at about 4-fold reduced activity com-
pared towild-typeCas9.At 37◦C, catalytic activity of tsRC9
was around 12-fold lower than at 29◦C (Figure 4A and
B). Experiments with paRC9 showed DNA cleavage at 7-
fold reduced rate compared to wild-type Cas9, indepen-
dent of whether experiments were conducted under dark
or blue-light conditions (Figure 4B, representative gels in
Supplementary Figure S11). We next assessed affinity for
a DNA target site in electrophoretic mobility shift assays
(EMSA). tsRC9 and paRC9 were incubated in presence
of dual crRNA:tracrRNA directed against a 90 base-pair
linear double-stranded DNA fragment. At 29◦C, tsRC9
showed tighter DNA binding than at 37◦C, with appar-
ent affinities of 44.3 ± 2.9 nM and 95.4 ± 7.7 nM, re-
spectively (Figure 4C and D). For paRC9, in line with the
DNA cleavage experiments, no light/dark difference was
observed, with apparent affinities of 73.9 ± 10.2 nM un-
der light and 74.4 ± 13.4 nM under dark conditions (Fig-
ure 4D, representative gels in Supplementary Figure S11).
For wild-type Cas9, an apparent affinity of 40.5 ± 5.9 nM
was observed for the substrate used (Supplementary Figure
S11b). Notably, all three proteins showed high degrees of
cooperativity.
These results suggest that paRC9 is a phenotypic switch,
while tsRC9 is inherently temperature-sensitive. However,
for tsRC9 there is also a discrepancy between the dynamic
ranges observed in E. coli (∼300-fold) and in biochemical
assays (2- and 12-fold). This could indicate that a combi-
nation of molecular properties and protein accumulation is
responsible for the full intracelluar effect, but there are also
other possible explanations for these discrepancies. First,
the short linear relaxed substrate used in the EMSA ex-
periments is rather unnatural in that Cas9 apparently dis-
plays higher reactivity towards negatively-supercoiledDNA
(9). Second, in a typical cellular setting, Cas9 needs to
find its target against a background of thousands of other
plasmid and genomic protospacer-adjacent-motif (PAM)
sites that are also sampled (41), while fewer ‘decoy’-PAMs
were present in the cleavage and EMSA experiments. Third,
the repressional effect on gene expression might be subject
to cellular amplification mechanisms and may hence scale
non-linearly with DNA-binding and DNA-cleavage activi-
ties.
To investigate the nature of the observed temperature de-
pendency of tsRC9, we performed thermal unfolding exper-
iments monitored by circular-dichroism (CD) spectroscopy
(Supplementary Figure S12, Table S4). A possible explana-
tion for the properties of tsRC9 would be global unfold-
ing between 29◦C and 37◦C. However, the observed melt-
ing point of tsRC9 was 42.7◦C, while wild-type Cas9 melted
at 44.2◦C. Although insertion of RsLOV apparently has a
small effect on global stability, these data rule out global un-
folding as a cause for the temperature sensitivity of tsRC9.
Because the isolated RsLOV domain had a melting point of
53.4◦C, complete unfolding of the RsLOV insert in tsRC9
between 29 and 37◦C is not likely either. Finally, to as-
sess whether differences in protein expression play a role in
paRC9 or tsRC9, we probed expression levels under assay
conditions by Western blot (Supplementary Figure S13).
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Figure 4. Biochemical investigation of tsRC9 and paRC9 DNA cleavage and binding activity. (A) tsRC9 cleavage of a plasmid-encoded target site at 29
and 37◦C. In the initial plasmid preparation, bands for the supercoiled (sc) and open-circular (oc) species are detected. Incubation with 50nM Cas9 for
1 h at 37◦C leads to complete digestion and a single band for the linear double-stranded species (li). Incubation with tsRC9 for 1, 2, 5, 10, 20, 40 and 60
minutes shows faster cleavage at 29◦C than at 37◦C. (B) Quantification of cleavage experiments for tsRC9 and paRC9 (n = 3, mean ± SD). For tsRC9, a
∼12× difference in initial reaction velocity is observed between 29◦C (open circles) and 37◦C (gray circles), while paRC9 shows no light-induced difference
in cleavage activity (open and gray squares). (C) Electrophoretic mobility shift assay (EMSA) for tsRC9 and a 90nt linear dsDNA (5nM concentration)
at 29◦C and 37◦C. Free and bound DNA are indicated. (D) Quantification of EMSA experiments for tsRC9 and paRC9 (n = 3, mean ± SD) A ∼2-fold
increased affinity is observed at 29◦C versus 37◦C for tsRC9, while paRC9 has identical affinities in light and dark. Crosses are data for wild-type Cas9.
overall expression in their respective on- (light for paRC9,
29◦C for tsRC9) and off-conditions (dark for paRC9, 37◦C
for tsRC9).
Regulation of endogenous genes with paRC9 and tsRC9
As paRC9 and tsRC9 were isolated based on repression of
plasmid-encoded genes, we next assessed to what extent dif-
ferent endogenous genes can be regulated in their expres-
sion with these constructs. To this end, we tried gRNAs that
target two genes of the well-characterizedE. coli lac operon:
lacZ encoding the enzyme -galactosidase, and lacI encod-
ing the regulatory LacI repressor which blocks transcrip-
tion of lacZ by binding to an upstream operator site O (12).
Presence of lactose or the non-hydrolyzable analog IPTG
induces LacZ expression by binding to LacI and causing it
to dissociate from the O site. Qi et al. previously showed
that a gRNA designed to repress LacZ expression com-
pletely abolished -galactosidase activity even in the pres-
ence of IPTG; by contrast, a gRNA against lacI induced
-galactosidase activity even in the absence of IPTG, albeit
not by as much as regular IPTG induction.
As a positive control, we used dCas9 and reproduced the
findings by Qi et al. (12) for gRNAs directed against the
lacI and lacZ genes (Figure 5A). For paRC9 with the lacZ
gRNA in the presence of IPTG, we observed no repression
of -galactosidase activity in the dark but a 3-fold repres-
sion in the light. When testing paRC9 with lacI gRNA in
the absence of IPTG, -galactosidase activity was induced
neither in the dark nor light (Figure 5A), indicating that
paRC9 fails to sufficiently repress lacI. We note that the
LacI repressor is a regulatory transcription factor, meaning
a few molecules per cell suffice to permanently occupy the
single-copy O site and repress -galactosidase expression.
-Galactosidase activity is hence not expected to scale lin-
early with LacI expression but rather show cooperative or
even step-wise dependency.
For tsRC9 with lacZ gRNA in the presence of IPTG,
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Figure 5. Repression of endogenous genes by tsRC9 and paRC9. (A) Transcriptional repression of genes from the lac operon was assessed by measuring
-galactosidase (gal) activity. Using a gRNA directed against the lacZ structural gene, tsRC9 completely represses gal activity at 29◦C, despite the
presence of the inductor IPTG. No repression is observed at 37◦C. With paRC9, no repression is observed in dark, but about 3-fold repression under blue
light. Using a gRNA directed against the gene encoding the LacI repressor, in the absence of IPTG, tsRC9 partly represses the LacI repressor at 29◦C, but
not at 37◦C. paRC9 shows no effect in either light or dark with this gRNA. Shown are mean ± SD of three individual experiments. (B) Temperature series
of tsRC9-induced repression showing that repression activity can be fine-tuned by growth temperature. gal-activity with lacZ gRNA (+IPTG) is shown
in gray circles, activity with lacI gRNA in open circles. gal-activity levels at full IPTG induction (dotted line), no induction (thick line), and at dCas9
+lacI gRNA-mediated induction (dashed line) are shown for comparison. Shown are mean ± SD of three individual experiments.
but no repression was seen at 37◦C. Using tsRC9 to-
gether with lacI gRNA in the absence of IPTG, at 29◦C -
galactosidase activity was induced by about half as much
as for dCas9 but not at all at 37◦C (Figure 5A). These re-
sults are consistent with the above finding for the plasmid-
based RFP gene that tsRC9 has similar repression activ-
ity as dCas9 at 29◦C but no detectable activity at 37◦C. To
better characterize the temperature dependency of tsRC9,
we also measured repression activities with lacZ and lacI
gRNAs at a range of temperatures between 29 and 37◦C
(Figure 5B). In case of the lacZ gRNA, repression of -
galactosidase activity by tsRC9 was comparable to dCas9
for 32◦C and lower temperatures but gradually attenuated
at higher temperatures and was completely lost at 37◦C.
For the lacI gRNA,-galactosidase induction gradually de-
creased between 29 and 33◦C, with no induction at higher
temperatures. These data suggest that tsRC9 can be used to
fine-tune expression levels of endogenous genes by culturing
bacteria at suitable temperatures.
DISCUSSION
In this work, we explored whether the RsLOV photosen-
sor can render an unrelated effector light-switchable, with
Cas9 as the proof-of-principle target. Using a comprehen-
sive domain-insertion library in combination with high-
throughput screening, we isolated the paRC9 variant that
showed light-switchable (d)Cas9 activity in three differ-
ent E. coli-based assays, namely plasmid cleavage, repres-
sion of plasmid-encoded genes and repression of endoge-
nous genetic loci. Removal of key residues engaged in LOV
photochemistry largely abolished light regulation, indicat-
ing that light-sensitivity of paRC9 is indeed dependent
on the integrity of the RsLOV insert. However, biochemi-
cal DNA cleavage and binding experiments failed to iden-
tify light-regulated activity in paRC9 under the conditions
investigated. Rather, paRC9 appears to be a phenotypic
switch that only manifests its switching properties in the
cellular context. Strikingly, from the same RsLOV-Cas9 li-
brary we also isolated a construct with strong temperature-
dependent activity, both when tested in E. coli and in bio-
chemical assays. While destabilization of proteins through
insertion of other domains is well known, the complete loss
of initial wild-type-like activity within a rather small win-
dow of 4–5◦C (Figure 5B) in tsRC9 is remarkable. To our
knowledge, tsRC9 represents the first case where a photo-
sensor bestows temperature sensitivity, and also the first re-
port of a temperature-sensitive Cas9 variant. These results
bring up two principal questions: (i) can RsLOV be used to
make other effector proteins light- and temperature sensi-
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We are cautiously optimistic that RsLOV can confer
temperature-sensitivity onto other effectors. In the naı¨ve
library, essentially every construct was devoid of activity
at 37◦C, indicating that the temperature sensitivity is inde-
pendent of insertion site and likely not predicated on spe-
cific interactions between RsLOV and Cas9. Moreover, re-
placing RsLOV with sfGFP largely abolished temperature-
sensitivity of tsRC9. These observations, combined with the
fact that a temperature effect is observed in biochemical
assays, suggest that the temperature sensitivity is rooted
in RsLOV itself. The transition window between ∼30◦C
and 37◦C would allow for a wide range of applications.
More studies are necessary, but RsLOV could serve as a
temperature-based ‘destabilizing domain’, analogous to the
ligand-based FKBP system (42).
Regarding the light dependence of paRC9, the situation is
less clear-cut. As a phenotypic switch, the light-dependent
activities observed in E. coli require the presence of other
cellular components, and may not be related to RsLOV
dimerization. In the naı¨ve library, light dependence was ap-
parently restricted to two insertion sites, and shifting the
paRC9A insertion site by three residues led to high consti-
tutive activity (Supplementary Figure S7), which suggests
that the observed behavior requires a particular orientation
ofRsLOV relative to Cas9. Initial experiments (Supplemen-
tary Figure S13) indicate that differences in protein accu-
mulation (which has been implicated for other phenotypic
switches) (39) are not responsible for the observed activity
difference. One hypothesis that could explain these data is
that the different molecular shape of RsLOV (5) in the light
state causes paRC9 to interact differently with cellular con-
stituents, as has been shown for other proteins (43). How-
ever, as the identity of the other required factors is unclear,
there are no simple experiments to prove or disprove this
hypothesis. Thus, while paRC9 shows that RsLOV can con-
fer light-sensitivity to an arbitrary effector, the mechanism
and transferability to other effectors remain unclear.
In terms of practical applicability, we believe that tsRC9
could be useful in several (d)Cas9 application scenarios,
while paRC9 is probably mostly suited for bacterial tran-
scriptional repression. In case a desired biological effect
can be obtained by a 3–6-fold difference in protein expres-
sion, the single-chain paRC9 would be the tool of choice
vis-a`-vis the other published light-switchable Cas9 con-
structs. For tsRC9, we have demonstrated efficient repres-
sion of plasmid- and chromosome-based loci in E. coli,
with the possibility of fine-tuning expression level by growth
temperature. While repression for lacI, and by implica-
tion other regulatory loci, is not complete, this could be
improved by multiplexing with several gRNAs (12). To
our knowledge, tsRC9 represents the first system to enable
temperature-sensitive, likely reversible and programmable
knockdown of arbitrary target genes in E. coli and possi-
bly other prokaryotes, with multiple potential applications
in synthetic biology and bacterial genetics (44,45). As tsRC9
shows temperature-sensitive DNA binding, other dCas9
mediated transcription-level applications (such as upregu-
lating genes through dCas9-activation domain fusions) can
likely also be achieved (13), although the dynamic ranges
observed in the present study may not be directly transfer-
able. tsRC9 could also be applied to transcriptional regu-
lation in eukaryotic cells (14), provided that the system un-
der study can withstand prolonged periods at∼30◦C.When
considering cleavage applications, we note that tsRC9 still
shows residual activity at 37◦C in the biochemical andE.coli
cleavage assays. Thus, a scenario that relies on robust activ-
ity at 29◦C, but complete prevention of even single cleavage
events at 37◦C is likely not achievable with tsRC9. However,
tsRC9 might offer new avenues towards preventing prob-
lems related to off-target cleavage and post-cleavage DNA
release (18,19).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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